However, current often epithelial cell adhesion molecule (EpCAM)-based detection methods, commonly used on peripheral blood (PB) samples, are limited to a few cancers with higher CTC numbers such as breast and prostate cancer, or very rare cases of patients with exceptionally high CTC numbers. Here, EPCAM is linked to Familial prostate cancer.